These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8912472)

  • 1. Molecular biology of prostate cancer.
    Shi XB; Gumerlock PH; deVere White RW
    World J Urol; 1996; 14(5):318-28. PubMed ID: 8912472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biologic aspects of human prostatic carcinoma.
    Netto GJ; Humphrey PA
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S57-64. PubMed ID: 7942612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular biology of prostate carcinoma].
    Urologe A; 1997 May; 36(3 Suppl Molekular):1-8. PubMed ID: 9304276
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic alterations in prostate adenocarcinoma.
    Prendergast NJ; Walther PJ
    Surg Oncol Clin N Am; 1995 Apr; 4(2):241-55. PubMed ID: 7796284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation in promoter region as biomarkers in prostate cancer.
    Yang M; Park JY
    Methods Mol Biol; 2012; 863():67-109. PubMed ID: 22359288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic changes in prostate cancer.
    Konishi N; Cho M; Yamamoto K; Hiasa Y
    Pathol Int; 1997 Nov; 47(11):735-47. PubMed ID: 9413032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of prostate cancer.
    Karayi MK; Markham AF
    Prostate Cancer Prostatic Dis; 2004; 7(1):6-20. PubMed ID: 14999233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of DNA methylation in prostate cancer development.
    Massie CE; Mills IG; Lynch AG
    J Steroid Biochem Mol Biol; 2017 Feb; 166():1-15. PubMed ID: 27117390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of prostate-cancer pathogenesis.
    Shand RL; Gelmann EP
    Curr Opin Urol; 2006 May; 16(3):123-31. PubMed ID: 16679847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of prostate cancer.
    Trapman J
    Eur J Cancer; 2001 Oct; 37 Suppl 7():S119-25. PubMed ID: 11887983
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of new prostate cancer progression markers by differential hybridization analysis.
    Schalken JA; Debruyne FM
    Eur Urol; 1992; 21 Suppl 1():60-5. PubMed ID: 1425840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recessive oncogenes.
    Bookstein R; Allred DC
    Cancer; 1993 Feb; 71(3 Suppl):1179-86. PubMed ID: 8428341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.
    Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ
    PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen signal transduction and prostatic carcinoma.
    Klocker H; Culig Z; Kaspar F; Hobisch A; Eberle J; Reissigl A; Bartsch G
    World J Urol; 1994; 12(2):99-103. PubMed ID: 8087144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism on androgen-independent progression of prostate cancer].
    Shimazaki J; Akakura K; Furuya Y; Ito H
    Nihon Rinsho; 1997 May; 55(5):1143-8. PubMed ID: 9155166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in human prostate cancer: a review of current literature.
    Ozen M; Pathak S
    Anticancer Res; 2000; 20(3B):1905-12. PubMed ID: 10928125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular analysis for prostate cancer].
    Ueda T; Suzuki H; Ichikawa T
    Nihon Rinsho; 2005 Feb; 63(2):213-7. PubMed ID: 15714968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanisms of prostatic oncogenesis].
    Zezerov EG; Severin ES
    Vestn Ross Akad Med Nauk; 1998; (5):29-35. PubMed ID: 9662994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of androgen-independent progression of prostatic carcinoma.
    Daliani D; Papandreou CN
    Semin Oncol; 1999 Aug; 26(4):399-406. PubMed ID: 10482182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.